HPSE in Ocular Herpes Infection
HPSE in Ocular Herpes Infection
批准号:
10753834
负责人:
DEEPAK SHUKLA
金额:
$42.28万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
未结题
起止时间:
2018-09-01 至 2027-08-31
关键词:
AddressAdverse effectsAlzheimer&aposs DiseaseAntiviral AgentsBindingBiological AssayBlindnessCause of DeathCell DeathCellsComplexCorneaCorneal DiseasesCyclic AMP-Dependent Protein KinasesCytoprotectionDNA DamageDNA RepairDataDiseaseEncephalitisEnvironmentEpithelial CellsExtracellular MatrixEyeEye InfectionsEye diseasesFatal OutcomeFundingGenetic TranscriptionGenotypeGrowth FactorHeparitin SulfateHerpesviridae InfectionsHerpesvirus 1Herpetic KeratitisHumanImmunoprecipitationImpairmentIn VitroIncidenceInfectionInflammationInflammatoryInvestigationKnowledgeMediatingMultiple SclerosisMusNervous SystemNeurodegenerative DisordersOcular PathologyPathologyPathway interactionsPhenocopyPhenotypePhosphorylationPhosphotransferasesProductionPrognosisProtein IsoformsProtein KinaseProteinsProteomicsProto-Oncogene Proteins c-aktPublishingRoleSeveritiesSeverity of illnessTestingTimeTissuesUlcerUp-RegulationVascular PermeabilitiesViralViral EncephalitisViral PathogenesisViral load measurementVirulence FactorsVirusVirus Replicationangiogenesiscorneal epitheliumcytokineexperimental studyheparanasein vivoinhibitorknock-downmetabolomicsmimicrymouse modelneovascularizationnerve damagenew therapeutic targetsmall moleculetranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
From the previous R01 funding period we have generated compelling new evidence that human Heparanase-1
(HPSE), a heparan sulfate (HS) endoglycosidase, is a virulence factor responsible for triggering angiogenesis
and inflammation in the eye during herpes simplex virus type-1 (HSV-1) infection. Our in vivo studies have shown
that HPSE presence can significantly increase HSV-1 replication and severity of ocular disease with poor
prognosis. Investigation of transcriptional and proteomic landscapes revealed a multitude of non-enzymatic roles
for HPSE during HSV-1 infection and identified new druggable targets. Upon further investigation, we found that
the significance of HPSE in corneal infection may not be limited to promoting viral pathogenesis only, but also in
the induction of inflammatory cell death in a protein kinase B (Akt) dependent manner. Making things even more
interesting and potentially more significant, our new preliminary data suggests that HPSE and Akt2 isoform
phenocopy each other both in inflammatory cell death and deficiency in virus production. Therefore, based on
our published observations of HPSE’s non-enzymatic roles and preliminary results, we hypothesize an important,
yet interconnected regulatory role for HPSE and Akt2 in HSV-1 mediated ocular inflammation, nerve damage,
and the resultant vision loss. We propose that their inhibition through small molecules can reduce disease
severity and viral replication in the eye and reduce the incidences of viral encephalitis. This proposal will focus
on understanding HPSE driven inflammatory cell death mechanisms and the role for Akt2 during HSV-1
replication, spread and disease pathology in the cornea. Successful completion of our studies will identify new
and more effective HPSE and Akt2 inhibitors that can reduce inflammation as well as virus load without causing
any adverse effects. Results generated through the proposed experiments will be broadly relevant, as aberrant
HPSE activity has been implicated in a wide array of ocular pathologies and other neurodegenerative diseases
and disorders such as multiple sclerosis and Alzheimer’s Disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HPSE in Ocular Herpes Infection
-
批准号:10242774
-
项目类别:
-
资助金额:$38.78万
-
财政年份:2018
-
负责人:DEEPAK SHUKLA
-
依托单位:
HPSE in Ocular Herpes Infection
-
批准号:10475706
-
项目类别:
-
资助金额:$38.78万
-
财政年份:2018
-
负责人:DEEPAK SHUKLA
-
依托单位:
A small molecule inhibitor of HSV genital infections
-
批准号:10205994
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2018
-
负责人:DEEPAK SHUKLA
-
依托单位:
A small molecule inhibitor of HSV genital infections
-
批准号:9763444
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2018
-
负责人:DEEPAK SHUKLA
-
依托单位:
HPSE in Ocular Herpes Infection
-
批准号:9761531
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2018
-
负责人:DEEPAK SHUKLA
-
依托单位:
A new molecular therapy against ocular herpes
-
批准号:10557908
-
项目类别:
-
资助金额:$47.61万
-
财政年份:2015
-
负责人:DEEPAK SHUKLA
-
依托单位:
A new molecular therapy against ocular herpes
-
批准号:8962978
-
项目类别:
-
资助金额:$39.95万
-
财政年份:2015
-
负责人:DEEPAK SHUKLA
-
依托单位:
A new molecular therapy against ocular herpes
-
批准号:9313256
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2015
-
负责人:DEEPAK SHUKLA
-
依托单位:
A new molecular therapy against ocular herpes
-
批准号:10363614
-
项目类别:
-
资助金额:$46.22万
-
财政年份:2015
-
负责人:DEEPAK SHUKLA
-
依托单位:
Novel Peptides Against Modified Heparan Sulfate
-
批准号:8917086
-
项目类别:
-
资助金额:$19.3万
-
财政年份:2014
-
负责人:DEEPAK SHUKLA
-
依托单位:
Novel Peptides Against Modified Heparan Sulfate
-
批准号:8702500
-
项目类别:
-
资助金额:$24.66万
-
财政年份:2014
-
负责人:DEEPAK SHUKLA
-
依托单位:
Role of Optineurin in Ocular Herpes Infection
-
批准号:8430175
-
项目类别:
-
资助金额:$23.93万
-
财政年份:2013
-
负责人:DEEPAK SHUKLA
-
依托单位:
Micro-nano Platforms for HSV Vaccine
-
批准号:8430071
-
项目类别:
-
资助金额:$23.93万
-
财政年份:2013
-
负责人:DEEPAK SHUKLA
-
依托单位:
Significance of heparan sulfate in HSV-1 spread
-
批准号:8510554
-
项目类别:
-
资助金额:$10.62万
-
财政年份:2009
-
负责人:DEEPAK SHUKLA
-
依托单位:
Molecular Mechanism of HSV Entry and Spread
-
批准号:7878408
-
项目类别:
-
资助金额:$1.56万
-
财政年份:2009
-
负责人:DEEPAK SHUKLA
-
依托单位:
Significance of heparan sulfate in HSV-1 spread
-
批准号:8106157
-
项目类别:
-
资助金额:$10.62万
-
财政年份:2009
-
负责人:DEEPAK SHUKLA
-
依托单位:
Significance of heparan sulfate in HSV-1 spread
-
批准号:7932799
-
项目类别:
-
资助金额:$10.62万
-
财政年份:2009
-
负责人:DEEPAK SHUKLA
-
依托单位:
Significance of heparan sulfate in HSV-1 spread
-
批准号:8304258
-
项目类别:
-
资助金额:$10.62万
-
财政年份:2009
-
负责人:DEEPAK SHUKLA
-
依托单位:
Significance of heparan sulfate in HSV-1 spread
-
批准号:7639893
-
项目类别:
-
资助金额:$10.62万
-
财政年份:2009
-
负责人:DEEPAK SHUKLA
-
依托单位:
Molecular Mechanism of HSV Entry and Spread
-
批准号:7342886
-
项目类别:
-
资助金额:$28.45万
-
财政年份:2005
-
负责人:DEEPAK SHUKLA
-
依托单位:
海外基金